2025年4月7日 星期一
首页        期刊介绍        编委会        投稿指南        期刊订阅        广告合作        联系我们        English
河北医学  2023, Vol. 29 Issue (1): 115-120    DOI: 10.3969/j.issn.1006-6233.2023.01.022
  临床研究 本期目录 | 过刊浏览 | 高级检索 |
急性胰腺炎患者血清miR-181a-5p表达及与Th17/Treg免疫平衡的关系
张瑜1, 辛前有1, 冯亚飞2, 郭伟2
1.山西省长治市北大医疗潞安医院普通外科, 山西 长治 046200
2.长治医学院附属和济医院胃肠外科, 山西 长治 046011
Relationship of Serum miR-181a-5p Expression with Th17/Treg Immune Homeostasis in Patients with Acute Pancreatitis
ZHANG Yu, XIN Qianyou, et al
Lu'an Hospital of Peking University, Shanxi Changzhi 046200, China
全文: PDF (1211 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的: 探讨急性胰腺炎(AP)患者血清微小RNA-181a-5p(miR-181a-5p)的表达及与辅助性T细胞17/调节性T细胞(Th17/Treg)免疫平衡的关系。方法: 选取2020年1月至2021年12月我院收治的110例AP患者(AP组),根据病情严重程度分为轻症AP组41例、中度重症AP组37例、重症AP组32例,另选取同期58名体检健康者(对照组)。采用酶联免疫吸附法检测外周血白细胞介素-6(IL-6)、IL-10、IL-17、转化生长因子-β1(TGF-β1)水平,流式细胞术检测外周血Th17、Treg百分比,qPCR检测血清miR-181a-5p表达。通过Pearson/Spearman相关性分析AP患者血清miR-181a-5p表达与Th17/Treg的相关性。结果: 与对照组比较,AP组血清miR-181a-5p表达和外周血Treg百分比降低,Th17百分比和Th17/Treg升高(P均<0.001)。与对照组比较,AP组外周血IL-6、IL-17水平升高,IL-10、TGF-β1水平降低(P均<0.001)。轻症、中度重症、重症AP组血清miR-181a-5p表达和外周血IL-10、TGF-β1、Treg百分比依次降低,外周血IL-6、IL-17、Th17百分比、Th17/Treg依次升高(P均<0.001)。Pearson/Spearman相关性分析显示,AP患者血清miR-181a-5p表达与IL-6、IL-17、Th17、Th17/Treg呈负相关(r/rs=-0.688、-0.652、-0.782、-0.825,P均<0.001),与IL-10、TGF-β1、Treg呈正相关(r/rs=0.743、0.667、0.739,P均<0.001)。结论: AP患者血清miR-181a-5p低表达,Th17/Treg免疫失衡,miR-181a-5p可能通过Th17/Treg免疫失衡参与AP发生发展。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 急性胰腺炎微小RNA-181a-5p辅助性T细胞17调节性T细胞    
AbstractObjective: To investigate the expression of serum microRNA-181a-5p (miR-181a-5p) in patients with acute pancreatitis (AP) and the relationship with T helper cell 17/T regulatory cell (Th17/Treg) immune homeostasis. Methods: 110 patients with AP admitted to our hospital from January 2020 to December 2021 (AP group) were selected and divided into the mild AP group (n=41), the moderately severe AP group (n=37)and the severe AP group (n=32) according to the severity of their conditions, and 58 healthy people with physical examination (control group) were also selected for the same period. Peripheral blood interleukin-6 (IL-6), IL-10, IL-17 and transforming growth factor-β1 (TGF-β1) levels were measured by enzyme-linked immunosorbent assay, peripheral blood Th17 and Treg percentages were measured by flow cytometry, and serum miR-181a-5p expression was measured by qPCR. Correlation of serum miR-181a-5p expression with Th17/Treg in AP patients was analyzed using Pearson/Spearman correlation. Results: Compared with the control group, serum miR-181a-5p expression and peripheral blood Treg percentage decreased, and Th17 percentage and Th17/Treg increased in AP group (all P<0.001). Compared with the control group, the peripheral blood levels of IL-6 and IL-17 in the AP group were increased, and the levels of IL-10 and TGF-β1 were reduced (all P<0.001). Serum miR-181a-5p expression and peripheral blood IL-10, TGF-β1, and Treg percentage were sequentially lower and peripheral blood IL-6, IL-17, Th17 percentage, and Th17/Treg were sequentially higher in the mild, moderately severe, and severe AP groups (all P<0.001). Pearson/Spearman correlation analysis showed that serum miR-181a-5p expression in AP patients was negatively correlated with IL-6, IL-17, Th17, and Th17/Treg (r/rs=-0.688, -0.652, -0.782, -0.825, all P<0.001) and positively correlated with IL-10, TGF-β1, and Treg were positively correlated (r/rs=0.743, 0.667, 0.739, all P<0.001). Conclusion: Serum miR-181a-5p is lowly expressed in AP patients with Th17/Treg immune imbalance. miR-181a-5p may be involved in the development of AP through Th17/Treg immune imbalance.
Key wordsAcute pancreatitis    MicroRNA-181a-5p    T helper cell 17    T regulatory cell
    
基金资助:山西省自然科学基金,(编号:201901D111331)
引用本文:   
张瑜, 辛前有, 冯亚飞, 郭伟. 急性胰腺炎患者血清miR-181a-5p表达及与Th17/Treg免疫平衡的关系[J]. 河北医学, 2023, 29(1): 115-120.
ZHANG Yu, XIN Qianyou, et al. Relationship of Serum miR-181a-5p Expression with Th17/Treg Immune Homeostasis in Patients with Acute Pancreatitis. HeBei Med, 2023, 29(1): 115-120.
链接本文:  
http://www.hbyxzzs.cn/CN/10.3969/j.issn.1006-6233.2023.01.022     或     http://www.hbyxzzs.cn/CN/Y2023/V29/I1/115
冀ICP备2025106803号    冀公网安备13080202000786号
版权所有 © 2016 《河北医学》杂志社
本系统由北京玛格泰克科技发展有限公司设计开发